Friday, December 26, 2025

Tag: pharmaceuticals

Why Analysts Favor Kiniksa Pharmaceuticals (KNSA)

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) is one of the most promising mid-cap healthcare stocks under $50. ...

Terns Pharmaceuticals (TERN) Climbs 53% on Stellar Leukemia Treatment Trial

We recently published 10 Stocks Delivering Explosive 18-190% Gains. Terns Pharmaceuticals, Inc. (NASDAQ:TERN) is one of...

Should You Invest in This Under-the-Radar Weight Loss Stock?

Vanda reported strong phase 2 results for a candidate that could be...

Why Crinetics Pharmaceuticals Stock Was Sliding on Friday

The stock of biotech Crinetics Pharmaceuticals (NASDAQ: CRNX) wasn't ending...

Novartis has stockpiles to withstand potential Trump tariffs, CEO says

ZURICH (Reuters) — Novartis (NVS) has increased its stockpiles of pharmaceuticals in the United States and...

LB Pharmaceuticals tops 2025 biotech IPO list with $285m Nasdaq debut

US-based biotech LB Pharmaceuticals has broken the 2025 biotech initial public offering (IPO) drought –...

2 Beaten-Down Stocks With Incredible Upside Potential

Recent history has, once again, demonstrated that...